Advisory Services Network’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$295K Buy
1,612
+47
+3% +$8.66K ﹤0.01% 1592
2025
Q4
$275K Sell
1,565
-227
-13% -$37.1K ﹤0.01% 1532
2025
Q3
$251K Buy
1,792
+68
+4% +$9.19K ﹤0.01% 1565
2025
Q2
$221K Sell
1,724
-344
-17% -$42.9K ﹤0.01% 1603
2025
Q1
$283K Sell
2,068
-654
-24% -$93.5K 0.01% 1338
2024
Q4
$416K Sell
2,722
-484
-15% -$81.6K 0.01% 1132
2024
Q3
$743K Hold
3,206
0.02% 822
2024
Q2
$743K Sell
3,206
-457
-12% -$99.3K 0.02% 822
2024
Q1
$790K Buy
3,663
+1,308
+56% +$306K 0.02% 778
2023
Q4
$609K Sell
2,355
-860
-27% -$211K 0.01% 815
2023
Q3
$826K Sell
3,215
-1,305
-29% -$349K 0.02% 706
2023
Q2
$1.29M Sell
4,520
-753
-14% -$224K 0.03% 544
2023
Q1
$1.47M Buy
5,273
+376
+8% +$104K 0.04% 504
2022
Q4
$1.36M Buy
4,897
+1,631
+50% +$461K 0.04% 496
2022
Q3
$872K Sell
3,266
-353
-10% -$75K 0.03% 589
2022
Q2
$739K Sell
3,619
-531
-13% -$109K 0.03% 673
2022
Q1
$874K Buy
4,150
+534
+15% +$116K 0.03% 669
2021
Q4
$868K Sell
3,616
-516
-12% -$133K 0.03% 678
2021
Q3
$1.17M Sell
4,132
-176
-4% -$57.7K 0.04% 550
2021
Q2
$1.49M Sell
4,308
-247
-5% -$74.8K 0.05% 472
2021
Q1
$1.27M Buy
4,555
+1,544
+51% +$416K 0.05% 471
2020
Q4
$738K Sell
3,011
-57
-2% -$14.7K 0.03% 594
2020
Q3
$870K Buy
3,068
+20
+0.7% +$5.58K 0.04% 446
2020
Q2
$815K Buy
3,048
+626
+26% +$188K 0.04% 437
2020
Q1
$766K Sell
2,422
-1,906
-44% -$578K 0.05% 406
2019
Q4
$1.28M Buy
4,328
+922
+27% +$256K 0.07% 360
2019
Q3
$797K Hold
3,406
0.05% 440
2019
Q2
$797K Buy
3,406
+568
+20% +$131K 0.05% 439
2019
Q1
$671K Sell
2,838
-514
-15% -$162K 0.05% 450
2018
Q4
$1.01M Sell
3,352
-76
-2% -$24.3K 0.09% 309
2018
Q3
$1.21M Sell
3,428
-2,391
-41% -$823K 0.09% 301
2018
Q2
$2.01M Sell
5,819
-1,120
-16% -$315K 0.15% 177
2018
Q1
$1.9M Buy
6,939
+746
+12% +$232K 0.15% 173
2017
Q4
$1.97M Buy
6,193
+329
+6% +$106K 0.17% 149
2017
Q3
$1.84M Buy
5,864
+2,903
+98% +$860K 0.21% 124
2017
Q2
$803K Buy
2,961
+58
+2% +$15.3K 0.1% 274
2017
Q1
$794K Buy
+2,903
New +$821K 0.12% 243
2016
Q3
$706K Buy
2,255
+251
+13% +$74.3K 0.13% 203
2016
Q2
$485K Buy
2,004
+437
+28% +$115K 0.11% 261
2016
Q1
$408K Sell
1,567
-114
-7% -$30.1K 0.11% 233
2015
Q4
$515K Buy
1,681
+253
+18% +$72.7K 0.17% 155
2015
Q3
$417K Sell
1,428
-965
-40% -$319K 0.13% 169
2015
Q2
$970K Sell
2,393
-447
-16% -$179K 0.29% 65
2015
Q1
$1.17M Buy
2,840
+912
+47% +$359K 0.32% 56
2014
Q4
$700K Sell
1,928
-2,106
-52% -$681K 0.22% 107
2014
Q3
$1.33M Sell
4,034
-1,202
-23% -$396K 0.49% 43
2014
Q2
$1.65M Buy
5,236
+136
+3% +$40.9K 0.7% 34
2014
Q1
$1.56M Buy
5,100
+1,605
+46% +$509K 0.8% 30
2013
Q4
$977K Buy
+3,495
New +$904K 0.49% 47

Other funds holding BIIB

Advisory Services Network's BIIB Position: Q1 2026 in Review

Advisory Services Network increased its Biogen (BIIB) stake by 3% in Q1 2026, buying an estimated $8.66K and bringing the position to 1,612 shares worth $295K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

Advisory Services Network first reported a position in BIIB in Q4 2013 and has held it in 49 quarters since. The position peaked at $2.01M in Q2 2018. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Advisory Services Network held 1,612 shares of Biogen worth $295K as of Q1 2026.
  • Advisory Services Network bought 47 Biogen shares in Q1 2026, an estimated $8.66K.
  • Biogen made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #1592 holding.
  • Advisory Services Network first reported a position in Biogen in Q4 2013 and has held it in 49 quarters since.
  • Advisory Services Network's Biogen position peaked at $2.01M in Q2 2018.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.